{"symbol":"BSX","fiscalQuarter":"Q3-2019","reportDate":"2019-10-23","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q3-2019","postBrief":{"headline":"Boston Scientific Beats on EPS, Stock Up 5.0%","keyNumbers":[{"metric":"EPS","actual":"$0.39","expected":"N/A","surprise":"+1.87%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed satisfaction with the EPS performance despite not providing revenue figures.","They highlighted ongoing investments in innovation as a key driver for future growth."],"summary":"Overall, management conveyed a positive outlook on the company's ability to manage costs and drive profitability. However, they did not provide specific guidance for future quarters."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report shows a solid performance with an EPS beat, which likely contributed to the stock's 5% increase. The positive reaction reflects investor confidence in the company's ongoing strategies, even without revenue details. The lack of guidance may leave some investors cautious, but the focus on innovation suggests a commitment to future growth.","metaDescription":"Boston Scientific (BSX) Q3 2019 earnings: EPS beat by 1.87%. Stock up 5.0%. Full breakdown."}}